US HB5145 | 2015-2016 | 114th Congress

Status

Spectrum: Bipartisan Bill
Status: Introduced on April 29 2016 - 25% progression, died in committee
Action: 2016-05-17 - Referred to the Subcommittee on Health.
Pending: House Subcommittee on Health Committee
Text: Latest bill text (Introduced) [PDF]

Summary

To amend title XIX of the Social Security Act to exclude abuse-deterrent formulations of prescription drugs from the Medicaid additional rebate requirement for new formulations of prescription drugs, and for other purposes. This bill amends title XIX (Medicaid) of the Social Security Act to exclude abuse-deterrent formulations of prescription drugs from the requirement that manufacturers of single-source or innovator drugs pay additional rebates to state Medicaid programs. Under current law, the Centers for Medicare & Medicaid Services (CMS) must use predictive modeling and other analytic technologies to identify improper Medicaid claims. The bill prohibits a state agency from using or disclosing such technologies except for purposes of administering a state Medicaid program or Children's Health Insurance Program (CHIP). A state agency shall have in effect adequate data security and control policies to ensure that access to such information is restricted to authorized persons for authorized uses. The bill places $5 million in the Medicaid Improvement Fund to be available beginning in FY2021.

Tracking Information

Register now for our free OneVote public service or GAITS Pro trial account and you can begin tracking this and other legislation, all driven by the real-time data of the LegiScan API. Providing tools allowing you to research pending legislation, stay informed with email alerts, content feeds, and share dynamic reports. Use our new PolitiCorps to join with friends and collegaues to monitor & discuss bills through the process.

Monitor Legislation or view this same bill number from multiple sessions or take advantage of our national legislative search.

Title

To amend title XIX of the Social Security Act to exclude abuse-deterrent formulations of prescription drugs from the Medicaid additional rebate requirement for new formulations of prescription drugs, and for other purposes.

Sponsors


History

DateChamberAction
2016-05-17HouseReferred to the Subcommittee on Health.
2016-05-06HouseReferred to the Subcommittee on Health.
2016-04-29HouseReferred to House Ways and Means
2016-04-29HouseReferred to House Energy and Commerce
2016-04-29HouseReferred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
2016-04-29HouseIntroduced in House

Same As/Similar To

HB4978 (Related) 2016-05-12 - Received in the Senate and Read twice and referred to the Committee on Finance.
HB5189 (Related) 2016-06-07 - Referred to the Subcommittee on Military Personnel.

Subjects


US Congress State Sources


Bill Comments

feedback